Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.6.1 (
sulfatase
)
3,205
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
A method was established for the determination of six compounds of zearalanol and related mycotoxins in pork and its products. After hydrolysis of the target compounds in the pork by beta-glucosidase/
sulfatase
, they were extracted with methanol aqueous solution and further purified by an HLB column. The separation was performed on a BEH C18 column with gradient elution using acetonitrile-water as mobile phases. The analytes were determined by mass spectrometry using electrospray ionization (ESI) in negative scan mode and multiple reaction monitoring (MRM) mode.
alpha-Zearalenol
-D7 and beta-zearalenol-D7 were used as internal standards. The good linearities (r > 0. 999) were achieved for the six compounds over the range of 1. 0 - 100 microg/L based on the internal standard calibration. The detection limits of the method were 0.03 -0.09 microg/kg. The mean recoveries of the six target compounds spiked at three levels from 1. 0 - 10. 0 microg/kg ranged from 76. 7% to 100. 5% with the relative standard deviations (RSDs) less than 20%. The proposed method is simple, sensitive, reproducible, and complies with the regulations for the determination of trace contaminant residues in food matrice.
...
PMID:[Determination of zearalanol and related mycotoxins in pork by solid-phase extraction coupled with ultra performance liquid chromatography-tandem mass spectrometry]. 2416 42